ABSTRACT Aflatoxins and their animal biotransformation products were screened for carcinogenic potential using the Ames' in vitro microbial detection system for carcinogens as bacterial mutagens [B. N. Ames et aL (1973) Proc (1) . The four naturally occurring AFs, aflatoxins B1 (AFB1), B2 (AFB2), G1 (AFG1), and G2 (AFG2), when administered as mixtures, were a potent class of animal hepatocarcinogens (2-6). They have been also associated with neoplastic formations in tissues and organs other than the liver (3, (6) (7) (8) (9) .
sence of the rat liver preparation, and this indicates none of the animal metabolites are the ultimate mutagenic and/or carcinogenic species. The relative mutagenic potency observed with this in vitro system qualitatively correlates with in vivo carcinogenic data. Comparison of both methods indicates: (i) aflatoxin B1 possessed the structure optimal for both mutagenicity and carcinogenicity, (ii) the decreased carcinogenicity of various animal metabolites is associated with their decreased mutagenicity, and (iii) the 2,3-double bond is involved in both the mutagenic and carcinogenic activity of aflatoxins. The Ames' assay has been demonstrated to be an extremely promising (toxicological) tool for the analysis of mycotoxins for mutagenic and/or carcinogenic activity.
Aflatoxins (AFs) ( Table 1) , a group of foodborne carcinogens produced by the molds Aspergillus flavus and parasiticus and their animal metabolism products, have been implicated in the etiology of human liver cancer (1) . The four naturally occurring AFs, aflatoxins B1 (AFB1), B2 (AFB2), G1 (AFG1), and G2 (AFG2), when administered as mixtures, were a potent class of animal hepatocarcinogens (2) (3) (4) (5) (6) . They have been also associated with neoplastic formations in tissues and organs other than the liver (3, (6) (7) (8) (9) .
Tests with rats (10) and rainbow trout (11) have revealed that AFB1 is a potent hepatocarcinogen; AFG1 is also considerably carcinogenic, but AFB2 and AFG2 possess much lower activity. Recent studies on the metabolism of AFB1 have resulted in the isolation and identification of numerous metabolites, all of minor structural variations but significantly different biological activity relative to the parent compound (12) .
Among these metabolites, aflatoxins Q, (AFQ1), M1 (AFM1), Bk (AFBa), and P1 (AFP1), aflatoxicol (AFL), and aflatoxicol H1 (AFLH1) ( Table 1) are the biotransformation products of AFB1 when the latter is incubated with liver preparations and a NADPH-generating system (13) (14) (15) (16) (17) . Since evidence has indicated that AFB1 requires metabolic activation for its toxic, mutagenic, and/or carcinogenic activity (18) (19) (20) (21) (22) , the toxicity of each metabolite has been of great interest in the search for the active molecular species. Attempts have been made to correlate the relative activity of the different metabolic pathways and the variations in the species susceptibility to aflatoxicosis (16, 23 (18, 21, 24) . This assay has shown considerable reliability in the detection of a large number of known carcinogens as bacterial mutagens (24, 25) . The analysis of the known major AF metabolites in our study permits an observation of the structureactivity relationships as related to the carcinogenic potential of the AFs.
MATERIALS AND METHODS
Chemicals are obtained as follows: AFBI, AFG1, AFB2, and AFG2 were purchased from Makor Chemicals, Ltd., Jerusalem, Israel. AFM1, AFQ1, and AFH1 were prepared by biotransformation of AFB1 using monkey liver homogenates (14, 17) . AFL was prepared by a similar biotransformation method to be published elsewhere. AFB2k and AFGk were chemically synthesized from AFB1 with dilute acid (27) . AFP1 was a chemically synthesized product kindly provided by G. N. Wogan, Massachusetts Institute of Technology, Cambridge, Mass. The purity and identity of all AFs was checked by fluorodensitometric analysis of thin-layer chromatography plates and mass spectrometry. In addition, AFQ1, AFM1, AFH1, and AFB2k were checked by high-pressure liquid chromatography (28) . All biochemicals, NADP+, glucose 6-phosphate, histidine, and biotin, were purchased from Sigma Chemicals, St. Louis, Mo.
The bacterial tester strain, Salmonella typhimurium strain TA 98 (21) , was the generous gift of B. N. Ames, University of California, Berkeley. The bacteria were stored and grown as outlined by McCann et al. (21) . The hepatic S-9 enzyme preparation was prepared from Charles River male white rats (200-250 g) and utilized according to procedures modeled after those outlined by Ames et al. (18) . Preliminary runs had determined the amount of S-9 equivalent to 18.75 mg of liver tissue per plate to be optimum for mutagenesis at the dose level of 0.2 ,g of AFB1 per plate. All AFs were dissolved in dimethylsulfoxide (Mallinckrodt); no more than 0.1 ml of dimethylsulfoxide was added per plate, an amount having no appreciable effect on the mutagenic response of the systems. Revertants were scored using a Bactronic colony counter. All experiments were performed under subdued light conditions.
Experiments were carried out in the predetermined linear dose-response range of each compound. The mutagenic activity of each compound tested was evaluated as the slope of the dose-response curve established by linear regression analysis on a Monroe 1766 calculator. Each data point contributing to the slope value represents a mean revertant number of triplicate (7) 25-400 ng (4) 50-800 ng (5) 50-800 ng (3) 25-400 ng (3) 100-2,000 ng (3) 100-3,200 ng (5) 100-66,000 ng (4) plates per dose concentration. The relative potency was determined by dividing the slope of the dose-response curve of each compound by the corresponding slope for AFB1.
RESULTS
The mutagenicity of the AFs and various animal metabolites and their relative potency are summarized in Table 1 in the order of decreasing potency. In agreement with results of mutagenicity tests using similar (18, 21) or different biological systems of detection (29) , AFB1 was found to be the most mutagenic of the four naturally occurring AFs while AFG1 was less mutagenic. AFB2 and AFG2 exhibited activity lower than that of controls, and therefore were assessed as nonmutagenic. Among the mammalian metabolites of AFB1, AFL was found to possess the greatest activity, followed by AFM1, AFLH1, AFQ1, AFP1, and AFB2.. The latter two were also found to be nonmutagenic. AFLH1 and AFQ1, both previously determined to be nonmutagenic using S. typhimurium TA 1538 (17, 30) , were found to be definitely mutagenic using the more sensitive tester strain TA 98. AFG2a, a possible metabolite of AFG1, was also assessed to be nonmutagenic in this assay.
DISCUSSION
The ability of the Ames'S. typhimurium-based assay to detect most known in vivo animal carcinogens as in vitro bacterial mutagens (18, 21, (24) (25) (26) makes this bacterial detection system an extremely promising tool in predicting carcinogenic potential of unknown compounds. The use of this bioassay on AFs of slight variation in molecular structure offers the possibility of studying the structure-mutagenicity and, perhaps, structure-carcinogenicity relationships. The examination of various AFB1 animal biotransformation products for their mutagenic activity, relative to the parent compound, is expected to aid in the elucidation of the events leading to AFB1 carcinogenesis, as related to its metabolism. Comparison of our experimental findings with available in dvo carcinogenic data for the naturally occurring AFs and various animal metabolites (Table 2) indicates a remarkable correlation between the in vitro bacterial mutagenicity of these compounds and their in divo animal carcinogenicity.
As reviewed by Magee (31) , various carcinogens are known to require metabolic activation to transform inactive molecules into ultimate mutagenic and/or carcinogenic species. In vivo studies do not clearly demonstrate this metabolic requirement for AFs, but microsomal enzyme activation is an absolute requirement for mutagenicity (18, 21) as is covalent interaction with DNA, RNA, and proteins (19, 20, 22) . Garner et al. (32) , using S. typhimurium strain TA 1530, a histidine auxotroph with a deletion through the DNA excision repair system, linked bactericidal activity of AFs to their microsomal enzyme-dependent covalent binding to nucleic acids.
The use of rat liver S-9 preparations as a model bioactivation center for AFs is especially relevant in view of the high susceptibility of the species to the hepatocarcinogenic effects of AFs. Our findings that all AFs require the presence of the rat liver S-9 preparation to exhibit mutagenic activity indicate that none of the AFs are mutagenically active per se. Thus, none of the animal biotransformation products are the ultimate mutagenic form generated through metabolic activation. Instead, all metabolites possessed substantially lower mutagenic activity than AFB1, indicating that they are probably products of metabolic detoxification. It is not known whether or not these metabolites are metabolically activated directly or biotransformed back into AFB1 and then activated by the rat liver S-9 preparation to the mutagenic form. In fact, AFL, a relatively mutagenic metabolite, and AFB2, of negligible activity, were both found to be readily convertible into AFB1 by duck hepatic cytoplasmic reductase systems (16, 33) . This activity, though not previously detected in the rat or the mouse, could possibly account for the activity of AFL. The inactivity of AFP1, the O-demethylated AFB1, provides further circumstantial evidence for metabolite mutagenicity via biotransformation back to AFB1, in that the demethylation at the methoxy-position of AFB1 with subsequent removal of the methyl group in the form of respired CO2 (34) is most likely irreversible. The reversibility of the various biotransformation pathways for AFB1 and the enzyme activity for AFs interconversion in the liver preparaBioch.emist : Wong and Hsieh tions of rats and other animals is currently under investigation.
The active form of AFB1 has been proposed to be the 2,3-epoxide generated metabolically from the 2,3-vinyl ether double bond in the terminal furan ring. Support for this structure came from the isolation of 2,3-dihydro-2,3-dihydroxy-AFB1, a postulated diol detoxification product, from acid hydrolysates of covalently linked complexes of AFB1 and nucleic acids generated in vitro (22) and in vlvo (35) . The epoxide itself, however, has not been isolated or synthesized, probably due to its extreme reactivity. Comparison of the mutagenic activity of the tested aflatoxins and the presence of the 2,3-vinyl ether double bond in the terminal furan ring seems to support the involvement of this functional group in toxicologic action. Calculations of electronic structure also demonstrate the 2,3-double bond to be the most probable site of the K-region and hence the most susceptible to electrophilic attack (36) .
The 2,3-vinyl ether double bond, however, does not seem to be the sole molecular site of the AFB1 molecule that determines mutagenic activity. Alterations occurring elsewhere in the molecule invariably result in the reduction of toxicity. Alterations of the cyclopentenone ring, such as its substitution by a terminal lactone ring as in AFG1, 7-hydroxylation in AFQ1, or reduction of the keto group as in AFL result in a significant lowering of mutagenic potential, despite the presence of an intact 2,3-double bond. The importance of the 2,3-epoxide of AFs has also been obscured by the findings that additions of cyclopropene oxide, an epoxide hydrase inhibitor, did not enhance the bactericidal action of AFB1 in a Salmonella/microsome assay (37) . But, this may indicate that the epoxide hydrase, metabolizing the AFBI-epoxide to the corresponding diol, may not be involved in the detoxification of the epoxide.
The experimental evidence accumulated thus far indicates that, of all of the isolated AFs and their animal biotransformation products, AFB1 has the molecular structure optimal for acute toxicity, mutagenicity, and carcinogenicity. Any changes in the bisfuran ring, the cyclopentenone ring, and the methoxy structures of AFB1 would result in marked reduction in biological activity. These changes in activity as a result of such structural alterations, at this stage of development, have to be interpreted not only in terms of susceptibility to epoxidation, but also interacellular transport, conjugation, and affinity to active or target sites.
